Combined vaccine compositions against hepatitis B virus and herpes simplex virus and possibly also epstein bar virus, hepatitis A amp; C viruses, human papilloma virus, varicella zoster virus, human cytomegalovirus, and toxoplasma gondii

摘要

A vaccine composition comprising: (a) A hepatitis B surface antigen; and (b) A Herpes simplex virus gD antigen. In conjunction with an adjuvant which is a preferential stimulator of TH1 cell response wherein the HBV antigen and the HSV antigen are not covalently linked to each other, and wherein the immune response to each antigen in the composition is essentially the same as that which is obtained by each antigen given individually.